Clinical development of two innovative pharmaceutical forms of leuprorelin acetate

Clinical development of two innovative pharmaceutical forms of leuprorelin acetate

Objectives: Two innovative pharmaceutical forms of leuprorelin acetate have been developed as 1-month and 3-month implants for the treatment of advanced hormone-dependent prostate cancer. These products contain active substance dispersed homogeneously in a biodegradable polymer. Here we present the...

Full description

Bibliographic Details
Main Authors: Goetz Geiges, Elisabeth Schapperer, Ursula Thyroff-Friesinger, Zoltán Vendel Engert, Patricia Gravel
Format: Article
Language:English
Published: SAGE Publishing 2013-02-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/1756287212471096

Similar Items

Similar Items